1 - 1 toradh á dtaispeáint as 1 toradh san iomlán ar an gcuardach 'on behalf of the FUTURE 2 study group', am iarratais: 0.02s Beachtaigh na torthaí
  1. 1
    Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

    Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the... de réir L. C. Coates, D. D. Gladman, P. Nash, O. FitzGerald, A. Kavanaugh, T. K. Kvien, L. Gossec, V. Strand, L. Rasouliyan, L. Pricop, K. Ding, S. M. Jugl, C. Gaillez, on behalf of the FUTURE 2 study group

    Foilsithe / Cruthaithe 2018-12-01
    Faigh an téacs iomlán
    Alt

Uirlisí cuardaigh: